Of the 28 ion channel drugs currently available, the 5 having distinct targets generate $12 billion in worldwide sales.

The completion of the human genome has provided the material for interrogation, screening, discovery, and development of many compounds that could be developed into drugs targeting ion channels. Due to new higher-throughput technological approaches currently under development, ion channels are experiencing a renewed interest from pharmaceutical and drug discovery companies. The deployment of ion channels for drug discovery is primarily driven by the large number of disease and therapeutic areas that are attributable to ion channel dysfunction. Some of these therapeutic areas include congenital, central nervous system, skeletal muscle, and kidney disorders, pain, and more.

Scope

D&MD's Ion Channels Market Analysis Report provides a comprehensive overview of the industry, qualitative analysis of the market, and a quantitative examination of the market opportunity (in various sub-sectors of ion channels). In addition, this Report focuses on the various technologies for ion channel screening.

Market Opportunities

• Develop and implement new technologies that are high content and high throughput in nature using validated reagents, cell lines, and consumables to address the remaining 370 unexplored ion channel genes.
• Produce the next generation of ion channel targeted drugs using the interrogation, screening, discovery, and development techniques acquired from the completion of the human genome.
• Become an authority by being among the first to invest in this relatively young marketplace.
• Capture market share through fulfilling the technological needs of the 3 core ion channel segments - primary screening, secondary screening, and safety/toxicity screening.

Key Reasons to Buy

• Discover the commercial viability of ion channel technology platforms through a detailed breakdown of their widespread uses and applications.
• Determine the full quantitative market potential of the various ion areas with an examination of the projected market impact through 2006.
• Recognize future growth areas within the ion channels industry via market model illustrating the qualitative and quantitative analysis, the growth drivers, and emerging trends.
• Learn about current and novel ion channel screening products from a complete assessment of each product and the manufacturers who seek to address the throughput bottleneck in the marketplace.
• Look inside the business strategies of key industry players with in-depth analyses of their technologies (including strengths and weaknesses), product pipelines, alliances, and more.
• Get a detailed overview of the structure and strategies of the ion channels marketplace via three graphic summaries outlining the key players, and the quantitative & technology analysis tailored for business planning, as well as corporate, investor, and business presentations (available upon request).